Form 4 for TMO Thermo Fisher Scientific
Accepted 2024-02-29 00:00:00 ET · period of report 2024-02-28 · accession 0001127602-24-007593 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-29 | 2024-02-28 | TMO | Lagarde Michel | EVP, COO | F - Tax | $572.03 | -1,013 | 18.1K | -5% | -$579.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-28 | F | D | 1,012.83 | $572.03 | 18,134.24 | D | — | — |